REAL208, a Liposome-based Formulation of Phosphodiesterase Inhibitor, Protects Acute Kidney Deficiency in Mice

Key Points

• Investigate the protective effects of REAL208, a liposomal formulation of dipyridamole, against acute kidney injury (AKI).
• Utilized a mouse model to simulate acute kidney injury.
• Administered liposomal dipyridamole and evaluated its effects.
• Assessed mitochondrial function, oxidative stress, and inflammation levels.
• Liposomal dipyridamole significantly preserved mitochondrial function.
• It effectively suppressed oxidative stress markers in kidney tissues.
• The formulation also reduced inflammation associated with acute kidney injury.